LGT Fund Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,111
Closed -$308K 256
2025
Q3
$308K Buy
3,111
+484
+18% +$48K 0.02% 211
2025
Q2
$240K Hold
2,627
0.02% 222
2025
Q1
$297K Buy
2,627
+317
+14% +$33.9K 0.03% 207
2024
Q4
$244K Hold
2,310
0.02% 236
2024
Q3
$244K Buy
+2,310
New +$252K 0.03% 200

Other funds holding ZBH

LGT Fund Management's ZBH Position: Q4 2025 in Review

LGT Fund Management sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 3,111 shares — an estimated $308K sold.

LGT Fund Management first reported a position in ZBH in Q3 2024 and held it in 5 quarters. The position peaked at $308K in Q3 2025. 949 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • LGT Fund Management reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • LGT Fund Management sold 3,111 Zimmer Biomet shares in Q4 2025, an estimated $308K.
  • LGT Fund Management first reported a position in Zimmer Biomet in Q3 2024 and held it in 5 quarters.
  • LGT Fund Management's Zimmer Biomet position peaked at $308K in Q3 2025.
  • 949 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on LGT Fund Management's 13F filing for Q4 2025, filed 5 Feb 2026.